A 68-year old male presenting with rhabdomyolysis-associated acute kidney injury following concomitant use of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate and pravastatin/fenofibrate: a case report.

A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981) 69.83

SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med (2008) 11.31

Industry sponsorship and research outcome. Cochrane Database Syst Rev (2012) 7.44

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA (2004) 5.25

Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation (2006) 4.35

Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med (2013) 4.35

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks. Lancet (2012) 3.29

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet (2012) 3.05

Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore) (2005) 2.93

Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clin Infect Dis (2005) 2.92

Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. J Clin Pharmacol (1993) 1.45

Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms. Am J Physiol Renal Physiol (2010) 1.15

Statin therapy in the elderly: a review. Arch Gerontol Geriatr (2009) 1.03

Renal effects of low dose aspirin in elderly patients. Isr Med Assoc J (2006) 0.98

Tenofovir-related nephrotoxicity: case report and review of the literature. Pharmacotherapy (2004) 0.95

Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin. J Clin Pharmacol (2014) 0.83

Severe raltegravir-associated rhabdomyolysis: a case report and review of the literature. Int J STD AIDS (2010) 0.82

Fenofibrate-associated nephrotoxicity: a review of current evidence. Am J Health Syst Pharm (2013) 0.82

Cobicistat, a pharmacoenhancer for HIV treatments. Drugs Today (Barc) (2013) 0.81

Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: a subanalysis of the USAGE study. J Clin Lipidol (2013) 0.80

An investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database). Int J STD AIDS (2013) 0.78